Castro-Balado, A.; BandÃn-Vilar, E.; Cuartero-MartÃnez, A.; GarcÃa-Quintanilla, L.; Hermelo-Vidal, G.; GarcÃa-Otero, X.; RodrÃguez-MartÃnez, L.; Mateos, J.; Hernández-Blanco, M.; Aguiar, P.;
et al. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence. Pharmaceutics 2022, 14, 2194.
https://doi.org/10.3390/pharmaceutics14102194
AMA Style
Castro-Balado A, BandÃn-Vilar E, Cuartero-MartÃnez A, GarcÃa-Quintanilla L, Hermelo-Vidal G, GarcÃa-Otero X, RodrÃguez-MartÃnez L, Mateos J, Hernández-Blanco M, Aguiar P,
et al. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence. Pharmaceutics. 2022; 14(10):2194.
https://doi.org/10.3390/pharmaceutics14102194
Chicago/Turabian Style
Castro-Balado, Ana, Enrique BandÃn-Vilar, Andrea Cuartero-MartÃnez, Laura GarcÃa-Quintanilla, Gonzalo Hermelo-Vidal, Xurxo GarcÃa-Otero, Lorena RodrÃguez-MartÃnez, Jesús Mateos, Manuela Hernández-Blanco, Pablo Aguiar,
and et al. 2022. "Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence" Pharmaceutics 14, no. 10: 2194.
https://doi.org/10.3390/pharmaceutics14102194
APA Style
Castro-Balado, A., BandÃn-Vilar, E., Cuartero-MartÃnez, A., GarcÃa-Quintanilla, L., Hermelo-Vidal, G., GarcÃa-Otero, X., RodrÃguez-MartÃnez, L., Mateos, J., Hernández-Blanco, M., Aguiar, P., Zarra-Ferro, I., González-Barcia, M., Mondelo-GarcÃa, C., Otero-Espinar, F. J., & Fernández-Ferreiro, A.
(2022). Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence. Pharmaceutics, 14(10), 2194.
https://doi.org/10.3390/pharmaceutics14102194